Department of Public Health, University of Helsinki, Helsinki, Finland.
BMJ Open. 2013 Jun 20;3(6):e002416. doi: 10.1136/bmjopen-2012-002416.
To determine whether vitamin C administration influences exercise-induced bronchoconstriction (EIB).
Systematic review and meta-analysis.
MEDLINE and Scopus were searched for placebo-controlled trials on vitamin C and EIB. The primary measures of vitamin C effect used in this study were: (1) the arithmetic difference and (2) the relative effect in the postexercise forced expiratory volume in 1 s (FEV1) decline between the vitamin C and placebo periods. The relative effect of vitamin C administration on FEV1 was analysed by using linear modelling for two studies that reported full or partial individual-level data. The arithmetic differences and the relative effects were pooled by the inverse variance method. A secondary measure of the vitamin C effect was the difference in the proportion of participants suffering from EIB on the vitamin C and placebo days.
3 placebo-controlled trials that studied the effect of vitamin C on EIB were identified. In all, they had 40 participants. The pooled effect estimate indicated a reduction of 8.4 percentage points (95% CI 4.6 to 12) in the postexercise FEV1 decline when vitamin C was administered before exercise. The pooled relative effect estimate indicated a 48% reduction (95% CI 33% to 64%) in the postexercise FEV1 decline when vitamin C was administered before exercise. One study needed imputations to include it in the meta-analyses, but it also reported that vitamin C decreased the proportion of participants who suffered from EIB by 50 percentage points (95% CI 23 to 68); this comparison did not need data imputations.
Given the safety and low cost of vitamin C, and the positive findings for vitamin C administration in the three EIB studies, it seems reasonable for physically active people to test vitamin C when they have respiratory symptoms such as cough associated with exercise. Further research on the effects of vitamin C on EIB is warranted.
确定维生素 C 给药是否会影响运动诱发的支气管收缩(EIB)。
系统评价和荟萃分析。
在 MEDLINE 和 Scopus 上搜索了关于维生素 C 和 EIB 的安慰剂对照试验。本研究中使用的维生素 C 效果的主要衡量标准是:(1)算术差,(2)维生素 C 期和安慰剂期之间运动后 1 秒用力呼气量(FEV1)下降的相对效果。对于报告了完整或部分个体水平数据的两项研究,通过线性模型分析了维生素 C 给药对 FEV1 的相对效果。通过逆方差法对维生素 C 给药的算术差异和相对效果进行了汇总。维生素 C 效果的次要衡量标准是维生素 C 日和安慰剂日参与者发生 EIB 的比例差异。
确定了 3 项研究维生素 C 对 EIB 影响的安慰剂对照试验。这些研究共有 40 名参与者。汇总的效果估计表明,运动前给予维生素 C 可使运动后 FEV1 下降减少 8.4 个百分点(95%CI 4.6 至 12)。汇总的相对效果估计表明,运动前给予维生素 C 可使运动后 FEV1 下降减少 48%(95%CI 33%至 64%)。其中一项研究需要进行插补才能纳入荟萃分析,但它还报告说,维生素 C 使发生 EIB 的参与者比例降低了 50 个百分点(95%CI 23 至 68);这种比较不需要数据插补。
鉴于维生素 C 的安全性和低成本,以及三项 EIB 研究中维生素 C 给药的阳性结果,对于有呼吸症状(如与运动相关的咳嗽)的活跃人群来说,在出现这些症状时测试维生素 C 似乎是合理的。需要进一步研究维生素 C 对 EIB 的影响。